Anti-malaria drug synthesized with the help of oxygen and light

Jan 17, 2012
Max Planck scientists have discovered a very simple way of synthesizing the artemisinin molecule, which is known as an anti-malaria drug from traditional Chinese medicine and has an extremely complex chemical structure. The discovery will pave the way for an inexpensive and large-scale production of artemisinin in the future. Credit: Peter H. Seeberger

The most effective anti-malaria drug can now be produced inexpensively and in large quantities. This means that it will be possible to provide medication for the 225 million malaria patients in developing countries at an affordable price. Researchers at the Max Planck Institute of Colloids and Interfaces in Potsdam and the Freie Universität Berlin have developed a very simple process for the synthesis of artemisinin, the active ingredient that pharmaceutical companies could only obtain from plants up to now. The chemists use a waste product from current artemisinin production as their starting substance. This substance can also be produced biotechnologically in yeast, which the scientists convert into the active ingredient using a simple yet very ingenious method.

There is an effective treatment against malaria, but it is not accessible to all of the more than 200 million people worldwide who are affected by the disease. Millions, especially in the developing world, cannot afford the combination drug preparation, which consists mainly of artemisinin. Moreover, the price for the medication varies, as this substance is isolated from sweet wormwood (Artemisia annua) which grows mainly in China and Vietnam, and varies seasonally in its availability. To make the drug affordable for at least some patients in , the Clinton Foundation, for example, subsidises its cost to the tune of several million dollars per year. Nevertheless, over one million people die of malaria each year because they do not have access to effective drugs.

This may be about to change. Peter H. Seeberger, Director at the Max Planck Institute of and Interfaces in Potsdam and Professor of Chemistry at the Freie Universität Berlin and his colleague François Lévesque have discovered a very simple way of synthesising the artemisinin molecule, which is known as an anti-malaria drug from traditional Chinese medicine and has an extremely complex chemical structure. "The production of the drug is therefore no longer dependent on obtaining the active ingredient from plants," says Peter Seeberger.

Synthesis from a by-product of artemisinin production

As a starting point, the chemists use artemisinic acid – a substance produced as a hitherto unused by-product from the isolation of artemisinin from sweet wormwood, which is produced in volumes ten times greater than the itself. Moreover, artemisinic acid can easily be produced in genetically modified yeast as it has a much simpler structure. "We convert the artemisinic acid into artemisinin in a single step," says Peter Seeberger. "And we have developed a simple apparatus for this process, which enables the production of large volumes of the substance under very controlled conditions." The only reaction sequence known up to now required several steps, following each of which the intermediate products had to be isolated laboriously – a method that was far too expensive to offer as a viable alternative to the production of the drug from plants.

The striking simplification of artemisinin synthesis required not only a keen sense for an elegant combination of the correct partial reactions to enable the process to take place in a single step; it also took a degree of courage, as the chemists departed from the paths typically taken by industry up to now. The effect of the molecule, which not only targets malaria but possibly also other infections and even breast cancer, is due to, among other things, a very reactive chemical group formed by two neighbouring oxygen atoms – which chemists refer to as an endoperoxide. Peter Seeberger and François Lévesque use photochemistry to incorporate this structural element into the artemisinic acid. Ultraviolet light converts oxygen into a form that can react with molecules to form peroxides.

800 photoreactors should suffice to cover the global requirement for artemisinin

"Photochemistry is a simple and cost-effective method. However, the pharmaceutical industry has not used it to date because it was so difficult to control and implement on a large scale," explains Peter Seeberger. In the large reaction vessels with which industrial manufacturers work, flashes of light do not penetrate deeply enough from outside and the reactive form of oxygen is not produced in sufficient volumes. The Potsdam-based scientists have succeeded in resolving this problem using an ingenious trick: They channel the reaction mixture containing all of the required ingredients through a thin tube that they have wrapped around a UV lamp. In this structure, the light penetrates the entire reaction medium and triggers the chemical conversion process with optimum efficiency.

"The fact that we do not carry out the synthesis as a one-pot reaction in a single vessel, but in a continuous-flow reactor enables us to define the reaction conditions down to the last detail," explains Peter Seeberger. After just four and a half minutes a solution flows out of the tube, in which 40 percent of the artemisinic acid has become artemisinin.

"We assume that 800 of our simple photoreactors would suffice to cover the global requirement for artemisinin," says Peter Seeberger. And it could all happen very quickly. Peter Seeberger estimates that the innovative synthesis process could be ready for technical use in a matter of six months. This would alleviate the global shortage of artemisinin and exert considerable downward pressure on the price of the associated drugs.

Explore further: Team pioneers strategy for creating new materials

More information: François Lévesque and Peter H. Seeberger, Continuous-Flow Synthesis of the Anti-Malaria Drug Artemisinin, Angewandte Chemie International Edition, 16 January 2012; DOI: 10.1002/anie.201107446

Related Stories

Scientists develop new drug treatment for malaria

Aug 16, 2010

As part of the £1.5 million project, researchers are now testing the drug to determine how the treatment could progress to clinical trials. The drug is made from simple organic molecules and will be cheaper to mass produce ...

Antimalarial drug artemisinin moves into production

Jul 12, 2010

(PhysOrg.com) -- A semi-synthetic version of the antimalarial drug artemisinin developed by UC Berkeley's Jay Keasling is moving out of development into full-scale production, helped along by a $10.7 million grant from the ...

A sweet defense against lethal bacteria

May 31, 2011

(PhysOrg.com) -- There is now a promising vaccine candidate for combating the pathogen which causes one of the most common and dangerous hospital infections. An international team of scientists from the Max ...

Recommended for you

Team pioneers strategy for creating new materials

Aug 29, 2014

Making something new is never easy. Scientists constantly theorize about new materials, but when the material is manufactured it doesn't always work as expected. To create a new strategy for designing materials, ...

Plug n' Play protein crystals

Aug 29, 2014

Almost a hundred years ago in 1929 Linus Pauling presented the famous Pauling's Rules to describe the principles governing the structure of complex ionic crystals. These rules essentially describe how the ...

Breaking benzene

Aug 27, 2014

Aromatic compounds are found widely in natural resources such as petroleum and biomass, and breaking the carbon-carbon bonds in these compounds plays an important role in the production of fuels and valuable ...

User comments : 2

Adjust slider to filter visible comments by rank

Display comments: newest first

antonima
not rated yet Jan 17, 2012
Its worth noting that cheap antibiotics don't always have a positive effect on the long term health of societies. If these antibiotics are applied too liberally antibiotic resistance will certainly follow.
gwrede
5 / 5 (1) Jan 18, 2012
Excellent work! These scientists should get a medal!

I wish there were more people like these guys.